{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast","title":"Episode 120. Ketamine for Benzodiazepine-Resistant Status Epilepticus – A Game-Changer?","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/9662700b\"></iframe>","width":"100%","height":180,"duration":663,"description":"Episode 120. Ketamine for Benzodiazepine-Resistant Status Epilepticus – A Game-Changer?\nIn this episode of The Pharm So Hard Emergency Medicine Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP dives deep into an exciting new study exploring ketamine as a rescue agent for benzodiazepine-resistant status epilepticus. Traditionally, managing refractory seizures often requires intubation, high-dose propofol, or other antiepileptics. But could ketamine provide rapid and effective seizure control in these critical moments?\nJimmy discusses key findings from the study, practical implications for the ED, and how this data could influence your choice of induction agents during intubation. Plus, he shares valuable clinical pearls and caveats when considering ketamine use in different patient populations.\n \n00:00 Introduction\n02:16 The Clinical Dilemma: Benzodiazepine-Resistant Status Epilepticus\n03:39 Introducing the Study: Ketamine as a Rescue Drug\n05:16 Key Findings: Rapid Seizure Termination\n06:05 Safety and Dosing Insights\n06:42 Clinical Implications: Ketamine in ED Practice\n07:05 Caveats and Patient Populations\n07:55 Conclusion","thumbnail_url":"https://img.transistorcdn.com/0slabNpqDiCXbVXLa2n3pgCJBybpmvn1oy523a_rHN8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDY1/ODFlMDllY2JhZTg2/YmQ0N2U5NTI2NjFh/MjQ4YS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}